Moving Towards Optimized Noncommunicable Disease ......REVIEW Moving Towards Optimized Noncommunicable Disease Management in the ASEAN Region: Recommendations from a Review and Multidisciplinary
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
R E V I EW
Moving Towards Optimized Noncommunicable
Disease Management in the ASEAN Region:
Recommendations from a Review and
Multidisciplinary Expert PanelThis article was published in the following Dove Press journal:
Risk Management and Healthcare Policy
Nina T Castillo-Carandang, 1
Robert D Buenaventura,2 Yook-
Chin Chia, 3 Dung Do Van, 4
Cheng Lee, 5 Ngoc Long Duong, 6
Chee H Ng, 7 Yolanda R Robles,8
Anwar Santoso, 9 Helen S Sigua, 10
Apichard Sukonthasarn, 11 Roger Tan,12
Eka Viora,13 Hazli Zakaria,14
Grace E Brizuela, 15
Priyan Ratnasingham,16
Mathew Thomas, 17 Anurita Majumdar16
1Department of Clinical Epidemiology, College of
Medicine, University of the Philippines Manila, Manila,
Philippines; and Institute of Clinical Epidemiology, National
Institutes of Health, University of the Philippines Manila,
Manila, Philippines;2Department of Psychiatry, Manila
Theological College - College of Medicine, Manila,
Philippines;3Department of Medical Sciences, School of
Healthcare and Medical Sciences, Sunway University,
Bandar Sunway, Selangor, Malaysia;4The University of
Medicine and Pharmacy at HoChi Minh City, Ho Chi Minh
City, Vietnam;5National Addictions Management Service,
Institute of Mental Health, Singapore;6Department of
Research, Education and Technology, Vietnam National
Heart Institute, Hanoi, Vietnam;7Department of
Psychiatry, The Melbourne Clinic and St Vincent’s
Hospital, University of Melbourne, Richmond, VIC,
Australia;8College of Pharmacy, University of the
Philippines Manila, Manila, Philippines;9Department of
Cardiology, Vascular Medicine, National Cardiovascular
Centre - Harapan Kita Hospital, Universitas Indonesia,
Jakarta, Indonesia;10University of the Philippines Open
University, Laguna, Philippines;11Department of Internal
Medicine, Faculty of Medicine, Chiang Mai University,
Chiang Mai, Thailand;12Roger Kidney Clinic, Gleneagles
accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properlyattributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Abbreviations: ASEAN, Association of Southeast Asian Nations; BMI, body mass index; BP, blood pressure; CVD, cardiovascular diseases; GPs, general physicians; HCPs,
healthcare professionals; NCDs, noncommunicable diseases; UHC, universal health coverage
Castillo-Carandang et al Dovepress
submit your manuscript | www.dovepress.com
DovePressRisk Management and Healthcare Policy 2020:13808
Abbreviations: ASEAN, Association of Southeast Asian Nations; BMI, body mass index; BP, blood pressure; HCPs, healthcare professionals; HPE, health professions
maybe extended to other NCDs such as diabetes, cancer and
chronic respiratory diseases as the NCD risk factors tend to
cluster together.2
Conclusion and Future DirectionsIdentifying implementation challenges and proposing solu-
tions for national and local NCD planning requires
a multistakeholder approach, which was addressed in this
study, partly, by engaging a multidisciplinary expert group.
Further operationalization of the recommendations included
in this paper requires commitment and participation from
other stakeholders such as policy makers.100 The implemen-
tation of NCD programs can be supported through public–
private partnerships; however, successful partnerships need
an established regulatory framework and clearly outlined
goals.101 Evidence-based digital technologies have the
potential to improve care coordination, prevent hospitaliza-
tions and reduce health wastage.102 Technologies such as
artificial intelligence have shown promise in assisting clin-
ical decision support, however these digital solutions need to
be rigorously evaluated for safe and effective as well as
ethical integration.103 Further research on patient beliefs
and health-seeking behavior in low-income settings and
their effect on healthy lifestyle can help tailor more effective
NCD prevention programs for the ASEAN region.104,105
AcknowledgmentsThe authors would like to thank Tanaya Bharatan,
Scientific Communications, Pfizer, and Kaveri Sidhu,
Scientific Communications, Pfizer for providing medical
writing support funded by Pfizer.
Author ContributionsAll authors made substantial contributions to conception
and design, acquisition of data, or analysis and interpreta-
tion of data; took part in drafting the article or revising it
critically for important intellectual content; gave final
approval of the version to be published; and agree to be
accountable for all aspects of the work.
FundingThis manuscript is based on the insights gathered at two
face-to-face meetings which were sponsored by Pfizer. The
development of this manuscript was funded by Pfizer. The
view and opinions expressed in this manuscript are those
of the authors.
DisclosureNTC has received personal fees from Pfizer for this work and
received grant and personal fees from Pfizer, consultancy fees
from United Laboratories (UNILAB) and personal fees from
Johnson & Johnson (Philippines) outside of the submitted
work. RB has received personal fees for lectures from Pfizer
(Philippines). YCC has received grants, personal fees and non-
financial support from Pfizer. DVD has received personal fees
and travel support from MSD, Pfizer and AstraZeneca and
received personal fees from Nestlé, Roche, Sandoz, Novartis
and Astra-Zeneca. CHN has received personal fees from
Pfizer. YR has received meeting honorarium from Pfizer. HZ
has received nonfinancial support from Pfizer as an invited
speaker. GEB, PR,MTandAM are employees of Pfizer. GEB,
PR and AM also hold shares in Pfizer. The authors report no
other conflicts of interest in this work.
References1. Noncommunicable diseases in the South-East Asia. 2019.
Available from: http://www.searo.who.int/entity/noncommunicable_diseases/en/. Accessed January, 2020.
2. Stein DJ, Benjet C, Gureje O, et al. Integrating mental health withother non-communicable diseases. BMJ. 2019;364:l295.doi:10.1136/bmj.l295
3. Dhillon PK, Jeemon P, Arora NK, et al. Status of epidemiology in theWHO South-East Asia region: burden of disease, determinants ofhealth and epidemiological research, workforce and trainingcapacity. Int J Epidemiol. 2012;41(3):847–860. doi:10.1093/ije/dys046
4. Institute for Health Metrics and Evaluation. GBD Compare (VizHub). 2019. Available from: https://vizhub.healthdata.org/gbd-compare/. Accessed January, 2020.
5. Frenk J, Gómez-Dantés O. The triple burden: disease in develop-ing nations. Harvard Int Rev. 2011;33(3):5.
6. Dans A, Ng N, Varghese C, Tai ES, Firestone R, Bonita R. The rise ofchronic non-communicable diseases in southeast Asia: time for action.Lancet. 2011;377(9766):680–689. doi:10.1016/S0140-6736(10)61506-1
7. Castillo-Carandang NT. Kagalingan: The Filipino’s Search forWell-Being, Happiness and Health. Amsterdam: Universiteit vanAmsterdam; 2019.
8. Noncommunicable diseases and mental health.Noncommunicable Diseases Country Profiles 2018. WorldHealth Organization. 2018. Available from: https://www.who.int/nmh/countries/en/. Accessed January, 2020.
9. Low WY, Lee YK, Samy AL. Non-communicable diseases in theAsia-Pacific region: prevalence, risk factors and community-basedprevention. Int J Occup Med Environ Health. 2015;28(1):20–26.doi:10.2478/s13382-014-0326-0
10. Rijal A, Adhikari TB, Khan JAM, Berg-Beckhoff G. The economicimpact of non-communicable diseases among households in SouthAsia and their coping strategy: a systematic review. PLoS One.2018;13(11):e0205745. doi:10.1371/journal.pone.0205745
11. World Economic Forum and Harvard School of Public Health.From burden to “best buys”: reducing the economic impact ofNCDs in low- and middle-income countries. 2011. Availablefrom: https://www.who.int/nmh/publications/best_buys_summary.pdf?ua=1. Accessed January, 2020.
Dovepress Castillo-Carandang et al
Risk Management and Healthcare Policy 2020:13 submit your manuscript | www.dovepress.com
12. World Economic Forum. Harvard School of Public Health. TheGlobal economic burden of non-communicable diseases. 2011.Available from: http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf. Accessed January, 2020.
13. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. Theburden and costs of chronic diseases in low-income andmiddle-income countries. Lancet. 2007;370(9603):1929–1938.doi:10.1016/S0140-6736(07)61696-1
14. Tackling NCDs: ‘Best buys’ and Other RecommendedInterventions for the Prevention and Control of NoncommunicableDiseases. 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/259232/WHO-NMH-NVI-17.9-eng.pdf?sequence=1&isAllowed=y. Accessed January, 2020.
15. Allen LN, Pullar J, Wickramasinghe KK, et al. Evaluation ofresearch on interventions aligned to WHO ‘Best Buys’ forNCDs in low-income and lower-middle-income countries:a systematic review from 1990 to 2015. BMJ Glob Health.2018;3(1):e000535. doi:10.1136/bmjgh-2017-000535
16. The Global Health Observatory. World Health Organization.2020. Available from: https://www.who.int/data/gho. AccessedMay, 2020.
17. Global Health Expenditure Database. 2017; http://apps.who.int/nha/database/country_profile/Index/en. Available from: AccessedJanuary, 2020.
18. The 2018 Update, Global Health Workforce Statistics. Geneva:World Health Organization; 2018. Available from: https://apps.who.int/gho/data/node.main.HWFGRP?lang=en. Accessed May,2020.
19. Essential Medicines and Basic Health Technologies forNoncommunicable Diseases: Towards a Set of Actions to ImproveEquitable Access in Member States. 2015. Available from: https://www.who.int/nmh/ncd-tools/targets/Final_medicines_and_technologies_02_07_2015.pdf. Accessed January, 2020.
20. Van Minh H, Pocock NS, Chaiyakunapruk N, et al. Progresstoward universal health coverage in ASEAN. Glob HealthAction. 2014;7(1):25856. doi:10.3402/gha.v7.25856
21. Myint CY, Pavlova M, Thein KN, Groot W. A systematic review ofthe health-financing mechanisms in the Association of SoutheastAsian Nations countries and the People’s Republic of China: lessonsfor the move towards universal health coverage. PLoS One. 2019;14(6):e0217278. doi:10.1371/journal.pone.0217278
22. Tien NTK, Tuan PL, Hung DV, et al. Joint annual health review:towards healthy ageing in Vietnam. 2017. Available from: http://jahr.org.vn/downloads/JAHR2016/JAHR2016_Edraft.pdf.Accessed January, 2020.
23. Agustina R, Dartanto T, Sitompul R, et al. Universal health coveragein Indonesia: concept, progress, and challenges. Lancet. 2019;393(10166):75–102. doi:10.1016/S0140-6736(18)31647-7
25. Noncommunicable Diseases in the South-East Asia Region. 2011.Available from: http://apps.searo.who.int/PDS_DOCS/B4793.pdf.Accessed January, 2020.
26. Lim J, Chan MM, Alsagoff FZ, Ha D. Innovations innon-communicable diseases management in ASEAN: a case series.Glob Health Action. 2014;7(1):25110. doi:10.3402/gha.v7.25110
27. Ezzati M, Pearson-Stuttard J, Bennett JE, Mathers CD. Acting onnon-communicable diseases in low- and middle-income tropicalcountries. Nature. 2018;559(7715):507–516. doi:10.1038/s41586-018-0306-9
28. NCD. Countdown collaborators. NCD Countdown 2030: worldwidetrends in non-communicable disease mortality and progress towardsSustainable Development Goal target 3.4. Lancet. 2018;392(10152):1072–1088. doi:10.1016/S0140-6736(18)31992-5
29. Martinez-Raga J, Amore M, Di Sciascio G, et al. 1st Internationalexperts’ meeting on agitation: conclusions regarding the currentand ideal management paradigm of agitation. Front Psychiatry.2018;9:54. doi:10.3389/fpsyt.2018.00054
30. Braun V, Clarke V. Using thematic analysis in psychology.Qual ResPsychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa
31. Nakamura K, Barzi F, Lam TH, et al. Cigarette smoking, systolicblood pressure, and cardiovascular diseases in the Asia-Pacificregion. Stroke. 2008;39(6):1694–1702. doi:10.1161/STROKEAHA.107.496752
32. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk ofmyocardial infarction in 27,000 participants from 52 countries: acase-control study. Lancet. 2005;366(9497):1640–1649.doi:10.1016/S0140-6736(05)67663-5
33. Lawes CM, Parag V, Bennett DA, et al. Blood glucose and risk ofcardiovascular disease in the Asia Pacific region. Diabetes Care.2004;27(12):2836–2842.
34. Barzi F, Patel A, Woodward M, et al. A comparison of lipidvariables as predictors of cardiovascular disease in the AsiaPacific region. Ann Epidemiol. 2005;15(5):405–413.
35. Asia Pacific Cohort Studies Collaboration. Cholesterol, diabetes andmajor cardiovascular diseases in the Asia-Pacific region.Diabetologia. 2007;50(11):2289–2297. doi:10.1007/s00125-007-0801-2
36. Kontis V, Mathers CD, Rehm J, et al. Contribution of six riskfactors to achieving the 25x25 non-communicable disease mor-tality reduction target: a modelling study. Lancet. 2014;384(9941):427–437. doi:10.1016/S0140-6736(14)60616-4
37. Lim KH, Fadhli M, Omar M et al. Technical report: evaluation ofeffectiveness of implementation of “Komuniti Sihat PerkasaNegara” (KOSPEN) programme in Malaysia- Phase 1. 2015.Available from: http://iku.moh.gov.my/images/IKU/Document/REPORT/2014/KOSPEN2014.pdf. Accessed January, 2020.
38. National Strategic Plan for Non-Communicable Disease: MediumTerm Strategic Plan to Further Strengthen the NCD Preventionand Control Program in Malaysia (2016-2025) 2016. Availablefrom: https://www.iccp-portal.org/system/files/plans/MYS_B3_NSP%20NCD%202016-2025%2C%20FINAL.pdf. AccessedMay, 2020.
39. Ling MY, Wan Shakira RH, Rosnah R, et al. Knowledge and accep-tance of community health intervention program in Sothern zone inPeninsular Malaysia among District Health Officers and KEMASDistrict Officers. Medical Journal of Malaysia. 2015;70(Supplement):1.
40. Global NCD Target: Improve Access to Technologies andMedicines to Treat NCDs. 2016. Available from: https://www.who.int/beat-ncds/take-action/policy-brief-improve-medicine-access.pdf. Accessed January, 2020.
41. Peltzer K, Pengpid S. Utilization and practice of Traditional/Complementary/Alternative Medicine (T/CAM) in SoutheastAsian Nations (ASEAN) member states. Stud Ethno-Med.2015;9(2):209–218. doi:10.1080/09735070.2015.11905437
42. Mattke S, Haims MC, Ayivi-Guedehoussou N, et al. Improvingaccess to medicines for non-communicable diseases in the devel-oping world. Rand Health Q. 2011;1(3):1.
43. Galema NA Hypertension and diabetes clubs in the governmentagencies. 2019. Available from: https://www.pulsus.com/proceedings/hypertension-and-diabetes-clubs-in-the-government-agencies-699.html. Accessed January, 2020.
Castillo-Carandang et al Dovepress
submit your manuscript | www.dovepress.com
DovePressRisk Management and Healthcare Policy 2020:13816
44. Geroy LS. Economic evaluation for first-line anti-hypertensivemedicines: applications for the Philippines. Cost Eff ResourAlloc. 2012;10(1):14. doi:10.1186/1478-7547-10-14
45. Free maintenance meds at DOH’s Hypertension and DiabetesClub. 2016. Available from: https://www.rappler.com/nation/118965-free-maintenance-medicines-doh-hypertension-diabetes-club. Accessed January, 2020.
46. Republic of the Philippines. Department of Health. Press Release.Please be careful with your heart, choose healthy options thisValentine’s day. 2017. Available from: https://www.doh.gov.ph/node/9296. Accessed January, 2020.
47. Report of the Commission on Ending Childhood Obesity. 2016.Available from: https://apps.who.int/iris/bitstream/handle/10665/204176/9789241510066_eng.pdf?sequence=1. Accessed January,2020.
48. Peltzer K, Pengpid S. Prevalence, risk awareness and healthbeliefs of behavioural risk factors for cardiovascular diseaseamong university students in nine ASEAN countries. BMCPublic Health. 2018;18(1):237. doi:10.1186/s12889-018-5142-1
49. He FJ, Wu Y, Feng XX, et al. School based education programmeto reduce salt intake in children and their families(School-EduSalt): cluster randomised controlled trial. BMJ.2015;350:h770. doi:10.1136/bmj.h770
50. Global Action Plan for the Prevention and Control ofNoncommunicable Diseases 2013-2020. 2013. Available from:https://apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdf?sequence=1. Accessed January, 2020.
51. Do HT, Santos JA, Trieu K, et al. Effectiveness ofa Communication for Behavioral Impact (COMBI) interventionto reduce salt intake in a vietnamese province based on estima-tions from spot urine samples. J Clin Hypertens (Greenwich).2016;18(11):1135–1142. doi:10.1111/jch.12884
52. Cummings KM. Programs and policies to discourage the use oftobacco products. Oncogene. 2002;21(48):7349–7364.doi:10.1038/sj.onc.1205810
53. “Sin Tax” Expands Health Coverage in the Philippines. 2015.Available from: https://www.who.int/features/2015/ncd-philippines/en/. Accessed January, 2020.
54. Austria MS, Pagaduan JA. Assessing the Impact of the PhilippineAssessing the Impact of the Philippine Sin Tax Reform Law onthe Demand for Cigarettes Sin Tax Reform Law on the Demandfor Cigarettes Working Paper Series Working Paper Series erSeries 2018-03-051. Manila, Philippines: De La SalleUniversity; 2018.
55. Salvador D Jr, Mo M, Sales K Higher alcohol taxes will improvepopulation health and augment UHC funds. 2019. Available from:https://www.bworldonline.com/higher-alcohol-taxes-will-improve-population-health-and-augment-uhc-funds/. Accessed January, 2020.
56. Department of Health. Sin Tax Law. Incremental Revenue forHealth: Annual Report 2019. 2019; Available from: https://www.doh.gov.ph/sites/default/files/publications/SinTax%202019%20Annual%20Report.pdf. Accessed January, 2020.
57. Dayrit MM, Lagrada LP, Picazo OF, et al. The Philippines HealthSystem Review. 2018. Available from: http://apps.searo.who.int/PDS_DOCS/B5438.pdf. Accessed January, 2020.
58. Arena R, Guazzi M, Lianov L, et al. Healthy lifestyle interventionsto combat noncommunicable disease-a novel nonhierarchical con-nectivity model for key stakeholders: a policy statement from theAmerican Heart Association, European Society of Cardiology,European Association for Cardiovascular Prevention andRehabilitation, and American College of Preventive Medicine. EurHeart J. 2015;36(31):2097–2109. doi:10.1093/eurheartj/ehv207
59. The power of cities: Tackling noncommunciable dieases and roadtraffic injuries. 2019. Available from: https://www.who.int/ncds/publications/tackling-ncds-in-cities/en/. Accessed January, 2020.
63. Psychiatrists and Nurses Working in Mental Health Sector (per100,000 population), 2014–2016. 2019. Available from: http://gamapserver.who.int/gho/interactive_charts/mental_health/psychiatrists_nurses/atlas.html. Accessed January, 2020.
64. Whooley MA, Avins AL, Miranda J, Browner WS. Case-findinginstruments for depression. Two questions are as good as many.J Gen Intern Med. 1997;12(7):439–445. doi:10.1046/j.1525-1497.1997.00076.x
65. Package of Essential Noncommunicable (PEN) DiseaseInterventions for Primary Health Care in Low-ResourceSettings. 2010. Available from: https://www.who.int/nmh/publications/essential_ncd_interventions_lr_settings.pdf. AccessedJanuary, 2020.
66. Ngo VK, Rubinstein A, Ganju V, et al. Grand challenges: inte-grating mental health care into the non-communicable diseaseagenda. PLoS Med. 2013;10(5):e1001443. doi:10.1371/journal.pmed.1001443
67. Kongsuk T, Supanya S, Kenbubpha K, Phimtra S, Sukhawaha S,Leejongpermpoon J. Services for depression and suicide inThailand. WHO South East Asia J Public Health. 2017;6(1):34–38. doi:10.4103/2224-3151.206162
68. Thawornchaisit P, de Looze F, Reid CM, Seubsman SA,Sleigh AC. Thai Cohort Study T. Health risk factors and theincidence of hypertension: 4-year prospective findings froma national cohort of 60 569 Thai Open University students. BMJOpen. 2013;3(6):6. doi:10.1136/bmjopen-2013-002826
69. World Health Organization. Country Office for Thailand.Hypertension care in Thailand: best practices and challenges,2019. 2019. Available from: https://apps.who.int/iris/handle/10665/330488. Accessed May, 2020.
70. Viswanathan M, Golin CE, Jones CD, et al. Closing the qualitygap: revisiting the state of the science (vol. 4: medication adher-ence interventions: comparative effectiveness). Evid Rep TechnolAssess (Full Rep). 2012;208(4):1–685.
71. FG Lin EH, Von Korff M, Katon W, et al. The role of the primarycare physician in patients’ adherence to antidepressant therapy.Med Care. 1995;33(1):67–74. doi:10.1097/00005650-199501000-00006
72. Chong Guan N, Zaini S. Shared decision making in the treatmentof depression. Malaysian J Psychiatry. 2018;27:2.
73. Lee YK, Ng CJ. The state of shared decision making in Malaysia.Z Evid Fortbild Qual Gesundhwes. 2017;123–124:66–68.doi:10.1016/j.zefq.2017.05.019
74. Zaini S, Manivanna Bharathy HA, Sulaiman AH, et al.Development of a strategic tool for shared decision-making inthe use of antidepressants among patients with major depressivedisorder: a focus group study. Int J Environ Res Public Health.2018;15:7. doi:10.3390/ijerph15071402
75. Elwyn G, Durand MA, Song J, et al. A three-talk model forshared decision making: multistage consultation process. BMJ.2017;359:j4891. doi:10.1136/bmj.j4891
76. Zwarenstein M, Goldman J, Reeves S. Interprofessional colla-boration: effects of practice-based interventions on professionalpractice and healthcare outcomes. Cochrane Database Syst Rev.2009;(3):CD000072.
77. Zimmerman J, Dabelko HI. Collaborative models of patient care:newopportunities for hospital social workers. Soc Work HealthCare. 2007;44(4):33–47. doi:10.1300/J010v44n04_03
Dovepress Castillo-Carandang et al
Risk Management and Healthcare Policy 2020:13 submit your manuscript | www.dovepress.com
78. Ko GT, So WY, Tong PC, et al. From design to implementation–the Joint Asia Diabetes Evaluation (JADE) program: a descriptivereport of an electronic web-based diabetes management program.BMC Med Inform Decis Mak. 2010;10(1):26. doi:10.1186/1472-6947-10-26
79. Chan JCN Designing a sustainable public-private-partnership pro-gram to enhance diabetes care and evaluating its impact using anoutcomes simulation model. 2017. Available from: https://www.pico.gov.hk/doc/en/research_report(PDF)/2015_A4_008_15C_Final_Report_Prof_Chan.pdf. Accessed January, 2020.
80. Chan J, So W, Ko G, et al. The Joint Asia Diabetes Evaluation(JADE) Program: a web-based program to translate evidence toclinical practice in Type 2 diabetes. Diabet Med. 2009;26(7):693–699. doi:10.1111/j.1464-5491.2009.02751.x
81. Beating non-communicable diseases in the community: The con-tribution of pharmacists. International Pharmaceutical Federation(FIP). 2019. Available from: https://www.fip.org/files/content/publications/2019/beating-ncds-in-the-community-the-contribution-of-pharmacists.pdf. Accessed January, 2020.
82. Ministry Of Health, Singapore. National Pharmacy StrategyInformation Pack. 2019. Available from: https://www.moh.gov.sg/docs/librariesprovider4/default-document-library/nps-info-pack_revised.pdf. Accessed January, 2020.
83. Liew I First pharmacists, advanced practice nurses certified toprescribe medicines. 2018; https://www.straitstimes.com/singapore/first-pharmacists-advanced-practice-nurses-now-certified-to-prescribe-medicines. Available from: Accessed January, 2020.
84. Mental Health Atlas 2011. 2011. Available from: https://apps.who.int/iris/bitstream/handle/10665/44697/9799241564359_eng.pdf?sequence=1. Accessed January, 2020.
85. Integrating Mental Health Services into Primary Health Care.2007. Available from: https://www.who.int/mental_health/policy/services/3_MHintoPHC_Infosheet.pdf. Accessed January, 2020.
86. Lim CG, Loh H, Renjan V, Tan J, Fung D. Child communitymental health services in Asia Pacific and Singapore’s REACHmodel. Brain Sci. 2017;7(12):10. doi:10.3390/brainsci7100126
87. Lewis T, Synowiec C, Lagomarsino G, Schweitzer J. E-health inlow- and middle-income countries: findings from the Center forHealth Market Innovations. Bull World Health Organ. 2012;90(5):332–340. doi:10.2471/BLT.11.099820
88. Patel A, Praveen D, Maharani A, et al. Association of multi-faceted mobile technology-enabled primary care interventionwith cardiovascular disease risk management in rural Indonesia.JAMA Cardiol. 2019;4(10):978–986. doi:10.1001/jamacardio.2019.2974
89. Assessing National Capacity for the Prevention and Control ofNoncommunicable Diseases: Report of the 2017 Global Survey.2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/276609/9789241514781-eng.pdf?ua=1. Accessed January,2020.
90. Varghese C, Nongkynrih B, Onakpoya I, McCall M, Barkley S,Collins TE. Better health and wellbeing for billion more people:integrating non-communicable diseases in primary care. BMJ.2019;364:l327. doi:10.1136/bmj.l327
91. Glossary. World Health Organization. 2016. Available from:https://www.who.int/global-coordination-mechanism/dialogues/glossary-whole-of-govt-multisectoral.pdf. Accessed January,2020.
92. Akeroyd JM, Chan WJ, Kamal AK, Palaniappan L, Virani SS.Adherence to cardiovascular medications in the South Asianpopulation: a systematic review of current evidence and futuredirections. World J Cardiol. 2015;7(12):938–947. doi:10.4330/wjc.v7.i12.938
93. Mahipala P, Dorji G, Tisocki K, Rani M. A critical review ofaddressing cardiovascular and other non-communicable diseasesthrough a primary health care approach in the South-East AsiaRegion. Cardiovasc Diagn Ther. 2019;9(2):150–157.doi:10.21037/cdt.2018.09.03
94. Maharani A, Sujarwoto PD, Oceandy D, Tampubolon G, Patel A.Cardiovascular disease risk factor prevalence and estimated10-year cardiovascular risk scores in Indonesia: theSMARThealth Extend study. PLoS One. 2019;14(4):e0215219.doi:10.1371/journal.pone.0215219
95. Bandar Seri Begawan Declaration on Noncommunicable Diseasesin ASEAN. 2013. Available from: https://www.asean.org/wp-content/uploads/images/archive/23rdASEANSummit/3.%20bsb%20declaration%20on%20ncd%20in%20asean-%20final-endorsed%2023%20september%202013.pdf. Accessed May, 2020.
96. ASEAN renews commitment for a healthier ASEAN. 2017. Availablefrom: https://asean.org/asean-renews-commitment-healthier-asean/?highlight=non-communicable%20diseases. Accessed May, 2020.
97. Van Bewer V. Transdisciplinarity in health care: a conceptanalysis. Nurs Forum. 2017;52(4):339–347. doi:10.1111/nuf.12200
98. WHO gets new advice on curbing deadly noncommunicable dis-eases. 2019. Available from: https://www.who.int/news-room/detail/10-12-2019-who-gets-new-advice-on-curbing-deadly-noncommunicable-diseases. Accessed May, 2020.
99. Asean Countries 2020. 2020. Available from: http://worldpopulationreview.com/countries/asean-countries/. Accessed May, 2020.
100. Peters DH, Peters MA, Wickramasinghe K, Osewe PL,Davidson PM. Asking the right question: implementationresearch to accelerate national non-communicable diseaseresponses. BMJ. 2019;365:l1868. doi:10.1136/bmj.l1868
101. Allen L, Bloomfield A; Working Group of the GlobalCoordination Mechanism on N. Engaging the private sector tostrengthen NCD prevention and control. Lancet Glob Health.2016;4(12):e897–e898. doi:10.1016/S2214-109X(16)30216-9
102. WHO Guideline: Recommendations on Digital Interventions forHealth System Strengthening 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/311941/9789241550505-eng.pdf. Accessed January, 2020.
103. Magrabi F, Ammenwerth E, McNair JB, et al. Artificial intelli-gence in clinical decision support: challenges for evaluating AIand practical implications. Yearb Med Inform. 2019;28(1):128–134. doi:10.1055/s-0039-1677903
104. The Nueva Ecija Cardiovascular Risk Experiment (NECVaRE).2019. Available from: https://clinicaltrials.gov/ct2/show/NCT03512691. Accessed January, 2020.
105. Palafox B, Seguin ML, McKee M, et al. Responsive andEquitable Health Systems-Partnership on Non-CommunicableDiseases (RESPOND) study: a mixed-methods, longitudinal,observational study on treatment seeking for hypertension inMalaysia and the Philippines. BMJ Open. 2018;8(7):e024000.doi:10.1136/bmjopen-2018-024000
Castillo-Carandang et al Dovepress
submit your manuscript | www.dovepress.com
DovePressRisk Management and Healthcare Policy 2020:13818
Risk Management and Healthcare Policy DovepressPublish your work in this journalRisk Management and Healthcare Policy is an international, peer-reviewed, open access journal focusing on all aspects of publichealth, policy, and preventative measures to promote good healthand improve morbidity and mortality in the population. The journalwelcomes submitted papers covering original research, basicscience, clinical & epidemiological studies, reviews and evaluations,
guidelines, expert opinion and commentary, case reports andextended reports. The manuscript management system is completelyonline and includes a very quick and fair peer-review system, whichis all easy to use. Visit http://www.dovepress.com/testimonials.phpto read real quotes from published authors.
Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journal
Dovepress Castillo-Carandang et al
Risk Management and Healthcare Policy 2020:13 submit your manuscript | www.dovepress.com